How would you like to take one injection that has multiple genes that improve cellular repair and regeneration, keeping your cells younger and healthier longer? Today, BioViva and Rutgers University are embarking on an ambitious research project to do just that; we are tackling humanities greatest foe — suffering and death due to aging.
Read the press release here:
https://www.eurekalert.org/pub_releases/2018-12/bui-rua121018.php
Today, we present an interview with Reason, the editor of Fight Aging! and co-founder of Repair Biotechnologies. We asked him about the state of rejuvenative therapies, some of which may be available in the near future.
Fight Aging! was the first blog that tackled the science of aging in a serious fashion. Many people still treat it as the go-to site for high-quality information and opinion on the rapidly growing field of biogerontology.
Reason (he goes by only his first name), the brain behind the Fight Aging! blog, has been involved in one way or another with anti-aging science for almost two decades as a writer, researcher, and investor. His new company, Repair Biotechnologies, is focused mainly on halting thymic atrophy and atherosclerosis, which causes about 20 percent of all human deaths.
Posted in biotech/medical, life extension | Leave a Comment on Happy to announce Dr. Manuel Serrano from the Institute for Research in Biomedicine (IRB) in Barcelona as a speaker for the 2019 Undoing Aging Conference
“Manuel has been a world-leading researcher in cell senescence for decades, and participated in various of our conferences starting many years ago. His latest breakthrough, which he will discuss in Berlin, is one of those head-slappingly brilliant concepts that I encounter at most once per year, combining a couple of long-established ideas in a completely novel way that potentially delivers far more than the sum of the parts. I won’t spoil the surprise here!” says Aubrey de Grey.
https://www.undoing-aging.org/news/dr-manuel-serrano-to-speak-at-undoing-aging-2019
#undoingaging #sens #foreverhealthy
Mild cognitive impairment (MCI) is an intermediate stage between the expected cognitive decline of normal aging and the more-serious decline of dementia. It can involve problems with memory, language, thinking, and judgment that are greater than normal age-related changes.
If you have mild cognitive impairment, you may be aware that your memory or mental function has “slipped.” Your family and close friends also may notice a change. But generally these changes aren’t severe enough to significantly interfere with your day-to-day life and usual activities.
Mild cognitive impairment may increase your risk of later progressing to dementia, caused by Alzheimer’s disease or other neurological conditions. But some people with mild cognitive impairment never get worse, and a few eventually get better.
A number of therapies that directly target the aging processes are currently in human trials and could change medicine significantly in the next decade if the results are positive.
What is aging?
Aging is basically the accumulation of damage and errors caused by a collection of varied processes that harm the functions of the body through the accumulation of waste, imperfect repair, the deregulation of cellular processes, the dysfunction of the immune system, chronic inflammation, and other disorders.
Today, we want to discuss this review published in the journal Science, as it provides a whistle-stop tour of caloric restriction, intermittent fasting, and time-restricted feeding.
There is a considerable amount of data supporting the effects of caloric restriction and similar dietary approaches on both health and lifespan in multiple species. In general, the more simple the organism, the greater the observed effect tends to be, although the effect is less so in longer-lived organisms. For example, caloric restriction has a significant effect on mouse lifespan, but it appears to do little, if anything, to the lifespan of humans.
Why is this? One explanation could be that, as humans, we have already evolved efficient repair systems that more thoroughly address the damages of aging than the repair systems of mice and other short-lived species. In other words, there is little improvement to be made to human repair systems compared to those of mice.
Project for Awesome (P4A) 2018 is finally here, and you can help us to win much-needed funds at no cost to you by voting for the videos supporting our charity.
Every year, a number of charities are chosen through voting, and they each receive a sum of money based on what the fundraiser at P4A has raised. In the past, charities have received around $25,000 each, which is a considerable sum, especially for a small non-profit org such as LEAF.
With these funds, we can purchase new equipment to support reporting at conferences and events and to bring our audience the best media experience possible. We are also planning to host a second conference in New York City in 2019, and this will be far more ambitious in scale and will be a two-day event rather than the single-day conference we held this year; with your support, we can make this one of the top conferences supporting the field of rejuvenation biotechnology and make high-quality footage available to the public. Finally, we can use the funds to hire new writers in order to bring you even more high-quality news articles and educational pieces about aging and research.
